NCT05949294View on ClinicalTrials.gov

Study of AROSOD-1 in Adult Participants With Amyotrophic Lateral Sclerosis (ALS)

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Amyotrophic Lateral Sclerosis
Interventions
DRUG

ARO-SOD1 Injection

single doses of ARO-SOD1 Injection by IT infusion

Sponsors
All Listed Sponsors
lead

Arrowhead Pharmaceuticals

INDUSTRY